Merck & Company to Present at GTCbio’s Targeted Designs for Clinical Trials Conference (July 19-20, Philadelphia, PA)
Monrovia, CA, May 12, 2007 --(PR.com)-- Dr. G. Frank Liu, Director, Vaccine Clinical Biostatistics at Merck & Company in New Jersey will give a presentation entitled “Efficient Flexible Designs to Target Various Treatment Effect Size in an Interval” at Targeted Designs for Clinical Trials Conference on July 19 – 20, 2007 in Philadelphia, PA.
Flexible sample size design such as group sequential, sample size re-estimation, and adaptive designs brings attractive properties in clinical trials. In this presentation, the concept and motivation of using flexible sample size design will be discussed when the unknown treatment difference is within a range rather than a fixed point value. Criteria to assess the performance of different flexible sample size designs will be introduced with the uncertainty of the true treatment difference in an interval. The method to construct an efficient flexible sample size design will be demonstrated with simulated examples.
GTCbio’s Targeted Designs for Clinical Trials Conference will take place at The Downtown Club on the 11th floor of Philadelphia’s Historic Public Ledger Building. The meeting addresses strategies to accelerate drug development, lower trial costs and reduce development risks.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://www.gtcbio.com/conference/conferenceDetails.aspx?id=97.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, christy.bowman@gtcbio.com
###
Flexible sample size design such as group sequential, sample size re-estimation, and adaptive designs brings attractive properties in clinical trials. In this presentation, the concept and motivation of using flexible sample size design will be discussed when the unknown treatment difference is within a range rather than a fixed point value. Criteria to assess the performance of different flexible sample size designs will be introduced with the uncertainty of the true treatment difference in an interval. The method to construct an efficient flexible sample size design will be demonstrated with simulated examples.
GTCbio’s Targeted Designs for Clinical Trials Conference will take place at The Downtown Club on the 11th floor of Philadelphia’s Historic Public Ledger Building. The meeting addresses strategies to accelerate drug development, lower trial costs and reduce development risks.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://www.gtcbio.com/conference/conferenceDetails.aspx?id=97.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, christy.bowman@gtcbio.com
###
Contact
GTCbio
Christy Bowman
626-256-6405
www.gtcbio.com
Christy Bowman
626-256-6405
www.gtcbio.com
Contact
Categories